Filing Details
- Accession Number:
- 0001493152-24-031439
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-12 21:58:49
- Reporting Period:
- 2024-08-12
- Accepted Time:
- 2024-08-12 21:58:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1958777 | Fibrobiologics Inc. | FBLG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569334 | Pete O'heeron | C/O Fibrobiologics, Inc. 455 E. Medical Center Blvd. Suite 300 Houston TX 77598 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-08-12 | 8,500 | $1.91 | 6,056,647 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiples transactions ranging from $1.82 to $2.017 on August 12, 2024. The reporting person will provide upon request to the SEC, the issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.